Kappa free light chains: Diagnostic performance in multiple sclerosis and utility in a clinical laboratory
- 29 January 2022
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 528, 56-64
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CISPLOS ONE, 2014
- Free light chain monomer–dimer patterns in the diagnosis of multiple sclerosisJournal of Immunological Methods, 2013
- The utility of cerebrospinal fluid analysis in patients with multiple sclerosisNature Reviews Neurology, 2013
- Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitudeJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Multiple sclerosisThe Lancet, 2008
- Differential diagnosis of suspected multiple sclerosis: a consensus approachMultiple Sclerosis Journal, 2008
- Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosisJournal of Neurology, 2008
- Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseasesEuropean Journal of Neurology, 2005
- Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple SclerosisArchives of Neurology, 2005
- Free kappa light chains in multiple sclerosis spinal fluidAnnals of Neurology, 1986